Medical cannabis for Crohn's disease — patient guide in Puerto Rico

Why it may help

Crohn's disease and other forms of inflammatory bowel disease involve chronic immune-driven inflammation of the digestive tract. The gut is rich in CB1 and CB2 cannabinoid receptors, and the body's own endocannabinoids — such as anandamide — help regulate intestinal motility, the gut's barrier function, pain signaling, and the activity of immune cells in the bowel lining. Because cannabinoids like THC and CBD interact with this same endocannabinoid system, particularly the CB2 receptors found on immune cells, researchers are studying whether they may help calm overactive inflammatory and pain pathways in the gut.

How patients use it

Most people with Crohn's disease who turn to medical cannabis are seeking relief from day-to-day symptoms rather than a change in the underlying disease itself. Cannabinoids may help ease abdominal pain and cramping, reduce nausea, and support appetite and food intake during flares. Some patients also report better sleep and a calmer relationship with eating, which can be difficult when the gut is inflamed. These are symptom-focused effects, and they vary from person to person.

Strength of the evidence

The scientific evidence for cannabis in Crohn's disease is still limited: research suggests it may improve symptoms and quality of life for some patients, but it has not been shown to reduce the underlying intestinal inflammation or change the course of the disease, and more rigorous study is needed.

Educational information grounded in established pharmacology and public sources. Not medical advice or a guarantee of results — treatment decisions are made with a licensed physician.

From the shelf

Where to start on the menu

Patients easing abdominal pain and nausea often start with our Wellness and Pain Relief shelves.

These are navigational suggestions by effect, not medical directions. What you feel depends on a product's chemistry and your body — talk with your physician and our staff.